2007 Annual Meeting | Neuro-ophthalmology
| 09:00 AM - 09:10 AM |
Case 1
Valerie Biousse, MD |
|
| 09:10 AM - 09:30 AM |
Diagnosis of Permanent Visual Loss
Nancy J. Newman, MD, FÂ鶹´«Ã½Ó³» |
|
| 09:30 AM - 09:40 AM |
Case 2
Valerie Biousse, MD |
|
| 09:40 AM - 10:00 AM |
Management of Optic Neuritis
Steven Galetta, MD, FÂ鶹´«Ã½Ó³» |
|
| 10:00 AM - 10:10 AM |
Case 3
Valerie Biousse, MD |
|
| 10:10 AM - 10:30 AM |
Diagnosis of Disc Edema
Kathleen B. Digre, MD, FÂ鶹´«Ã½Ó³» |
|
| 10:30 AM - 10:50 AM |
Break
|
|
| 10:50 AM - 10:55 AM |
Case 4
Valerie Biousse, MD |
|
| 10:55 AM - 11:10 AM |
Transient Visual Loss
Valerie Biousse, MD |
|
| 11:10 AM - 11:15 AM |
Case 5
Valerie Biousse, MD |
|
| 11:15 AM - 11:30 AM |
Interpretation of Visual Fields
Jonathan D. Trobe, MD, FÂ鶹´«Ã½Ó³» |
|
| 11:30 AM - 12:15 PM |
Unknown Cases (6, 7)
Simmons Lessell, MD |
|
| 12:15 PM - 01:30 PM |
Lunch
|
|
| 01:30 PM - 01:40 PM |
Case 8
Valerie Biousse, MD |
|
| 01:40 PM - 02:00 PM |
Diagnosis of Diplopia
Valerie Biousse, MD |
|
| 02:00 PM - 02:10 PM |
Case 9
Valerie Biousse, MD |
|
| 02:10 PM - 02:30 PM |
Anisocoria
Steven Galetta, MD, FÂ鶹´«Ã½Ó³» |
|
| 02:30 PM - 02:40 PM |
Case 10
Valerie Biousse, MD |
|
| 02:40 PM - 02:55 PM |
Management of Third Nerve Palsies
Jonathan D. Trobe, MD, FÂ鶹´«Ã½Ó³» |
|
| 02:55 PM - 03:00 PM |
Case 11
Valerie Biousse, MD |
|
| 03:00 PM - 03:20 PM |
Supranuclear Deficits
Mark L. Moster, MD, FÂ鶹´«Ã½Ó³» |
|
| 03:20 PM - 03:45 PM |
Break
|
|
| 03:45 PM - 05:00 PM |
Unknown Cases (12, 13, 14)
Simmons Lessell, MD |
| Valerie Biousse, MD | Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Topcon. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care. |
| Nancy J. Newman, MD, FÂ鶹´«Ã½Ó³» | Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phelcom. The institution of Dr. Newman has received research support from GenSight. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. |
| Mark L. Moster, MD, FÂ鶹´«Ã½Ó³» | Dr. Moster has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gensight . Dr. Moster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viridian. Dr. Moster has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kilcoyne and Nesbitt. |
| Kathleen B. Digre, MD, FÂ鶹´«Ã½Ó³» | Dr. Digre has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Headache Society. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuro-ophthalmology. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Utah Womens Health Review. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care. |
| Steven Galetta, MD, FÂ鶹´«Ã½Ó³» | Dr. Galetta has nothing to disclose. |
| Jonathan D. Trobe, MD, FÂ鶹´«Ã½Ó³» | No disclosure on file |
| Simmons Lessell, MD | No disclosure on file |